Treatment of refractory malignant lymphoma with intensive chemoradiotherapy and autologous marrow transplantation
β Scribed by G. Phillips; J. Fay; G. Herzig; R. Herzig; H. Lazarus; S. Wolff
- Book ID
- 112212107
- Publisher
- AlphaMed Press
- Year
- 1986
- Tongue
- English
- Weight
- 161 KB
- Volume
- 4
- Category
- Article
- ISSN
- 1066-5099
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Twenty patients with disseminated non-Hodgkin's lymphoma who failed conventional combination chemotherapy were treated with high-dose chemoradiotherapy and marrow transplantation from an HLA-identical sibling. Four patients remain alive in complete remission from 153 to 784 days after transplant. Th
Autologous bone marrow transplantation (ABMT) following intensive therapy regimes is being used increasingly in relapsed lymphomas. To date no randomised studies have been performed to ascertain the value of this form of therapy. We describe here our experience of ABMT in both Hodgkin's disease and